Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Driven by the downstream end-users, the market of Nuclear Medicine & Radio Pharmaceuticals witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Nuclear Medicine & Radio Pharmaceuticals market is offered. The research provides insights for the global Nuclear Medicine & Radio Pharmaceuticals market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Nuclear Medicine & Radio Pharmaceuticals industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Nuclear Medicine & Radio Pharmaceuticals Market Segmentations:

    By Players:

    • Siemens Healthcare

    • Biosensors International Group, Ltd.

    • Esaote

    • GE Healthcare

    • Toshiba

    • TriFoil Imaging

    • Shimadzu

    • Philips Healthcare

    • Hitachi

    • Carestream


    By Types:

    • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

    • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.


    By End-User:

    • Diagnostic Applications: SPECT, PET.

    • Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Nuclear Medicine & Radio Pharmaceuticals Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Nuclear Medicine & Radio Pharmaceuticals Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine & Radio Pharmaceuticals Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Types

      • 1.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. from 2013 to 2025

      • 1.3.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by End-Users

      • 1.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Applications: SPECT, PET. from 2013 to 2025

      • 1.4.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumNuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Nuclear Medicine & Radio Pharmaceuticals Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine & Radio Pharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

      • 3.4.2 Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.


    4 Segmentation of Nuclear Medicine & Radio Pharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine & Radio Pharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine & Radio Pharmaceuticals for Diagnostic Applications: SPECT, PET.

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine & Radio Pharmaceuticals for Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.


    5 Market Analysis by Major Regions

    • 5.1 Global Nuclear Medicine & Radio Pharmaceuticals Production Analysis by Major Regions

    • 5.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Analysis by Major Regions

    • 5.3 Global Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis


    6 Product Commodity of Nuclear Medicine & Radio Pharmaceuticals Market in Major Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 7.1 North America Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 7.2 North America Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 7.3 North America Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Countries

      • 7.3.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 7.3.2 Canada Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 7.3.3 Mexico Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate


    8 Europe Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 8.1 Europe Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 8.2 Europe Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 8.3 Europe Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Countries

      • 8.3.1 Germany Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.2 UK Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.3 France Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.4 Italy Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.6 Spain Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.7 Belgium Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.8 Poland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.9 Russia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 8.3.10 Turkey Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate


    9 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 9.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 9.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Countries

      • 9.3.1 China Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 9.3.2 Japan Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 9.3.4 India Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 9.3.6 South Korea Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 10.3.2 Brazil Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 10.3.3 Nigeria Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

      • 10.3.4 South Africa Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate 

      • 10.3.5 Argentina Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Siemens Healthcare

      • 11.1.1 Siemens Healthcare Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Biosensors International Group, Ltd.

      • 11.2.1 Biosensors International Group, Ltd. Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Esaote

      • 11.3.1 Esaote Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 GE Healthcare

      • 11.4.1 GE Healthcare Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Toshiba

      • 11.5.1 Toshiba Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 TriFoil Imaging

      • 11.6.1 TriFoil Imaging Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Shimadzu

      • 11.7.1 Shimadzu Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Philips Healthcare

      • 11.8.1 Philips Healthcare Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Hitachi

      • 11.9.1 Hitachi Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Carestream

      • 11.10.1 Carestream Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 86 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. from 2013 to 2025

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Diagnostic Applications: SPECT, PET. from 2013 to 2025

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine & Radio Pharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine & Radio Pharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine & Radio Pharmaceuticals by Different Types from 2013 to 2025

    • Table Consumption Share of Nuclear Medicine & Radio Pharmaceuticals by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

    • Figure Market Size and Growth Rate of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine & Radio Pharmaceuticals by Different End-Users from 2013 to 2025

    • Table Consumption Share of Nuclear Medicine & Radio Pharmaceuticals by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Diagnostic Applications: SPECT, PET.

    • Figure Market Size and Growth Rate of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

    • Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Major Regions

    • Table Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Regions

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Regions in 2013

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Regions in 2018

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Share by Major Regions in 2025

    • Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Regions

    • Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Regions

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Regions in 2013

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Regions in 2018

    • Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Regions in 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine & Radio Pharmaceuticals market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2013 to 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2013

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2018

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2013

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2018

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2013

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2018

    • Figure North America Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2025

    • Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2013 to 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2013

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2018

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2013

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2018

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Europe Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2025

    • Figure Germany Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure France Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2013

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2018

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2013

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2018

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2025

    • Figure China Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandNuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure India Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine & Radio Pharmaceuticals Consumption Share by Major Countries in 2025

    • Figure GCC Countries Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Siemens Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare

    • Figure Revenue and Market Share Analysis of Siemens Healthcare

    • Table Product and Service Introduction of Siemens Healthcare

    • Table Company Profile and Development Status of Biosensors International Group, Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biosensors International Group, Ltd.

    • Figure Sales and Growth Rate Analysis of Biosensors International Group, Ltd.

    • Figure Revenue and Market Share Analysis of Biosensors International Group, Ltd.

    • Table Product and Service Introduction of Biosensors International Group, Ltd.

    • Table Company Profile and Development Status of Esaote

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Esaote

    • Figure Sales and Growth Rate Analysis of Esaote

    • Figure Revenue and Market Share Analysis of Esaote

    • Table Product and Service Introduction of Esaote

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Toshiba

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toshiba

    • Figure Sales and Growth Rate Analysis of Toshiba

    • Figure Revenue and Market Share Analysis of Toshiba

    • Table Product and Service Introduction of Toshiba

    • Table Company Profile and Development Status of TriFoil Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TriFoil Imaging

    • Figure Sales and Growth Rate Analysis of TriFoil Imaging

    • Figure Revenue and Market Share Analysis of TriFoil Imaging

    • Table Product and Service Introduction of TriFoil Imaging

    • Table Company Profile and Development Status of Shimadzu

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shimadzu

    • Figure Sales and Growth Rate Analysis of Shimadzu

    • Figure Revenue and Market Share Analysis of Shimadzu

    • Table Product and Service Introduction of Shimadzu

    • Table Company Profile and Development Status of Philips Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philips Healthcare

    • Figure Sales and Growth Rate Analysis of Philips Healthcare

    • Figure Revenue and Market Share Analysis of Philips Healthcare

    • Table Product and Service Introduction of Philips Healthcare

    • Table Company Profile and Development Status of Hitachi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hitachi

    • Figure Sales and Growth Rate Analysis of Hitachi

    • Figure Revenue and Market Share Analysis of Hitachi

    • Table Product and Service Introduction of Hitachi

    • Table Company Profile and Development Status of Carestream

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Carestream

    • Figure Sales and Growth Rate Analysis of Carestream

    • Figure Revenue and Market Share Analysis of Carestream

    • Table Product and Service Introduction of Carestream


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.